RP Witherspoon

Lockheed Martin (United States) — United States

Medicine · Health Sciences

31h-index7.7kcitations70works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(55), Polyomavirus and related diseases(16), T-cell and B-cell Immunology(11), Transplantation: Methods and Outcomes(10), Antifungal resistance and susceptibility(7)

Publications64 total

In-Flight Calibration and Performance of the OSIRIS-REx Touch And Go Camera System (TAGCAMS)
Space Science Reviews·2020· 29 cited
Fukushima Rescue Mission Lasting Legacy: Radioactive Contamination of Americans
Japan focus·2013Open Access
Personalized Dosing of Cyclophosphamide in the Total Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients with Hematologic Malignancy
Biology of Blood and Marrow Transplantation·2009Open Access
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation
Bone Marrow Transplantation·2003· 103 cited
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities
Bone Marrow Transplantation·2000· 58 cited
Secondary Malignancies after Allogeneic or Autologous Marrow Transplantation
Beiträge zur Onkologie/Contributions to oncology·2000· 4 cited
Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation
Blood·1997· 352 cited
Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantation
Blood·1996· 4 citedOpen Access
Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.
PubMed·1996· 15 cited
Pregnancies following high-dose cyclophosphamide with or without high- dose busulfan or total-body irradiation and bone marrow transplantation
Blood·1996· 721 citedOpen Access
Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients
Blood·1996· 28 citedOpen Access
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors
Blood·1996· 109 citedOpen Access
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors
Blood·1996· 3 cited
T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life.
PubMed·1995· 253 cited
Late complications of allogeneic and autologous marrow transplantation.
PubMed·1992· 109 cited
Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone [letter; comment]
Blood·1992· 1 citedOpen Access
Marrow transplantation for malignant plasma cell disorders: Summary of the Seattle experience*
European Journal Of Haematology·1989· 40 cited
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration
Blood·1988· 6 citedOpen Access
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration
Blood·1988· 74 citedOpen Access
Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted, or HLA-identical marrow grafts.
PubMed·1988· 30 cited
page 1 of 4Next →

Frequent Co-authors

Rainer Storb(25), H. Joachim Deeg(20), Thomas Ed(18), CD Buckner(18), FR Appelbaum(15), KM Sullivan(14), KC Doney(12), JE Sanders(11), K Doney(10), PL Weiden(9), Keith M. Sullivan(9), KM Sullivan(8), Claudio Anasetti(8), Clift Ra(8), Jack W. Singer(7), F R Appelbaum(7), JA Hansen(7), Paul J. Martin(6), K Atkinson(5), Jan‐Stephan Sanders(5)